Story

Salesforce Faces High Bar for Earnings After 31% Rally, UBS Warns

ENTHMSVIIDZHZH-TWJAKOHI
Aug 12, 20262 min read
Salesforce Faces High Bar for Earnings After 31% Rally, UBS Warns
Text size
Background

Salesforce (CRM) shares have rallied 31% since their June 22 low, but analysts at UBS are expressing caution ahead of the company's upcoming earnings report, suggesting the significant run-up has created an asymmetrically negative risk profile for the stock.

Analyst View: Rally Raises the Stakes

According to UBS, the recent surge in Salesforce's stock was driven by a confluence of factors, including a rotation of capital from semiconductor and AI-focused stocks into more defensive software names. The bank also noted that fears of AI displacing enterprise software revenue have so far appeared overstated, while a narrative has emerged that application-layer companies like Salesforce could benefit from a multi-model AI market.

However, the core of the UBS thesis is that this rally has already priced in a significant second-half business acceleration. Analysts argue that the market's margin for error has now evaporated, and any disappointment or tempering of that growth narrative in the upcoming report would likely not be tolerated by investors.

Earnings in Focus

Salesforce is scheduled to report its quarterly results on August 26 after the market closes. The current consensus estimate is for earnings per share (EPS) of $3.28 on revenue of $11.33 billion. While the company has a strong track record of beating EPS estimates for four consecutive quarters, its performance last quarter serves as a cautionary tale.

Sample IUX Markets – In-articleAd

Despite reporting an EPS that beat estimates by nearly 24%, the stock fell -1.62% following the announcement. This reaction signals that investors are looking for more than a simple earnings beat; they are seeking clear evidence of accelerating growth to justify the stock's higher valuation.

Conflicting Signals for Investors

The bull case for Salesforce remains supported by solid fundamentals. According to the source, 24 analysts have revised earnings estimates upward, and the company boasts strong gross margins of 78% and an attractive free cash flow yield of 10%. Recent business wins, including a $5.6 billion U.S. Army contract, and aggressive share buybacks also point to underlying strength.

Conversely, the technical picture reflects the current uncertainty. While short-term charts show bullish momentum, the longer-term monthly chart remains in a downtrend, with the price below its 10-month simple moving average of $199.50. UBS's stance is to remain on the sidelines heading into the report, concluding that the risk/reward profile is unfavorable after the sharp recovery.

Read next

More on Stocks
Back to latest news

LATEST